Clinical trial

Neurofilament Light Chain ,Chitinase-3 Like-1 Proteins and Plasmacytoid Dendritic Cells in Multiple Sclerosis

NCT05451069

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Study at a glance

Registry-backed

Neurofilament Light Chain ,Chitinase-3 Like-1 Proteins and Plasmacytoid Dendritic Cells in Multiple Sclerosis

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov
StatusUNKNOWN
Study typeOBSERVATIONAL
Start date2022-10-01
PhaseN/A
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.